BVMF/E1LV34 (BVMF/E1LV34)

Brazil Stock Exchange: BVMF/E1LV34 · BRL

R$403

+0.00 (0.0%)· Recorded snapshot

Market cap	486.9B
Revenue (ttm)	1T
Net income (ttm)	26.6B
EPS (ttm)	R$25.2
P/E (trailing)	16.0x
P/E (forward)	14.5x
Dividend	R$4.80 (1.19%)
Volume	0
Beta	0.71

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1T
Net income (ttm): 26.6B
EPS (ttm): R$25.2
P/E (trailing): 16.0x
P/E (forward): 14.5x
Market cap: 486.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E14.5

P25 11.9P50 16.2P75 25.4

Trailing P/E16

P25 14.9P50 23.3P75 39

ROE11.5

P25 2.2P50 10.8P75 20.1

ROIC8.6

P25 6.2P50 12.2P75 21.3

All BVMF/E1LV34 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-21
Employees	96,615
Employees change	-7,100
Employees growth	-6.81%
Enterprise value	BRL 596.7B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-07-12
Fiscal year end	December
Founded	2001
Industry	Healthcare Plans
Is primary listing	No
ISIN number	BRE1LVBDR002
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	BRL 486.9B
Next earnings date	2027-01-27
Price	BRL 403.00
Price currency	BRL
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-09
Symbol	bvmf/E1LV34
Website	https://www.elevancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.54x
Average P/E ratio (3Y)	16.27x
Average P/E ratio (5Y)	17.1x
Earnings yield	6.27%
EV/Earnings	22.41x
EV/EBIT	13.9x
EV/EBITDA	12.6x
EV/FCF	17.68x
EV/Sales	0.55x
FCF / EV yield	5.66%
FCF yield	6.93%
Forward P/E	14.51x
Graham number	308.53422
Graham upside	-23.44%
Lynch fair value	BRL 110.16
Lynch upside	-72.67%
P/(FCF - SBC) ratio	14.98x
P/(OCF - SBC) ratio	12.78x
P/B ratio	2.1x
P/E ratio	15.96x
P/FCF ratio	14.43x
P/OCF ratio	12.38x
P/S ratio	0.47x
Price / tangible book value	17.21x
Price/EBITDA ratio	10.79x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.98%
EBITDA margin	4.32%
Effective tax rate	18.35%
FCF margin	3.1%
Gross margin	26.43%
Operating margin	3.98%
Pretax margin	3.1%
Profit margin	2.55%
Profit per employee	BRL 275,521
Profitable quarters	105
Profitable years	28
Revenue per employee	BRL 10.8M
ROA	4%
ROA (5Y)	5.41%
ROCE	9.89%
ROE	11.48%
ROE (5Y)	15.57%
ROIC	8.65%
ROIC (5Y)	11.02%
SBC / revenue	0.12%
Tax / revenue	0.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-3.9%
EPS growth (Q)	17.86%
EPS growth (QoQ)	-6.56%
EPS growth 10Y	10.65%
EPS growth 3Y	-2.28%
EPS growth 5Y	1.06%
EPS growth quarters	1
EPS growth years	0
FCF growth	72.92%
FCF growth (Q)	29.03%
FCF growth (QoQ)	-38.5%
FCF growth 3Y	-7.56%
FCF growth 5Y	-7.23%
Net income growth	-7.12%
Net income growth (Q)	14.8%
Net income growth (QoQ)	-6.7%
Net income growth 3Y	-5.01%
Net income growth 5Y	-1.41%
Net income growth quarters	1
Net income growth years	0
OCF growth	54.64%
OCF growth (Q)	11.63%
OCF growth (QoQ)	-33.77%
OCF growth 10Y	6.78%
OCF growth 3Y	-7.23%
OCF growth 5Y	-6.28%
Revenue growth	3.6%
Revenue growth (Q)	1.42%
Revenue growth (QoQ)	1.89%
Revenue growth 10Y	9.24%
Revenue growth 3Y	6.17%
Revenue growth 5Y	8.56%
Revenue growth quarters	56
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -5.6B
EBIT	BRL 41.6B
EBITDA	BRL 45.1B
EPS	BRL 25.25
Financing cash flow	BRL -15.2B
Free cash flow	BRL 33.7B
Free cash flow minus SBC	BRL 32.5B
Gross profit	BRL 276.3B
Income taxes	BRL 5.9B
Investing cash flow	BRL -15.6B
Net borrowing	BRL 3.2B
Net cash flow	BRL 8.5B
Net income	BRL 26.6B
Operating cash flow minus SBC	BRL 38.1B
Operating income	BRL 41.6B
Revenue	BRL 1T
Stock-based compensation	BRL 1.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 1,070.93
Debt / EBITDA	3.47
Debt / equity	0.69
Debt / FCF	4.72
Goodwill	BRL 152.7B
Interest coverage	5.55
Net cash (debt)	BRL -105.7B
Net cash / market cap	-21.71%
Net debt / EBITDA	2.34
Net debt / equity	0.46
Net debt / FCF	3.13
Piotroski F-Score	5
Property, plant and equipment	BRL 24.8B
Shareholders' equity	BRL 232B
Tangible book value	BRL 28.3B
Tangible book value per share	BRL 130.89
Total assets	BRL 662B
Total cash	BRL 196B
Total debt	BRL 159.3B
Total liabilities	BRL 430B
WACC	7.1%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current ratio	1.47
Net working capital	BRL 61.6B
Quick ratio	1.34
Working capital	BRL 113.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.33%
Dividend growth	-6.16%
Dividend growth (3Y)	6.56%
Dividend growth (5Y)	7.67%
Dividend growth years	5
Dividend payment date	2026-12-28
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 4.80
Dividend yield	1.19%
Ex-dividend date	2026-12-03
Last dividend	BRL 1.17
Payout ratio	29.17%
Shareholder yield	4.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 435.07
1D price change	0%
1M price change	-1.9%
1M total return	-1.61%
1W price change	-1.9%
1W total return	-1.61%
1Y price change	3.92%
1Y return CAGR	5.34%
1Y total return	5.34%
20-day SMA	BRL 385.50
200-day SMA	BRL 463.97
3M price change	-4.78%
3M total return	-4.5%
3Y price change	-9.07%
3Y return CAGR	-2.01%
3Y total return	-5.91%
50-day SMA	BRL 366.92
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 436.03
52-week high date	2026-07-13
52-week low	BRL 288.00
52-week low date	2026-03-09
5Y price change	-5.22%
5Y return CAGR	-0.08%
5Y total return	-0.41%
6M price change	24.77%
6M total return	25.5%
All-time high	BRL 638.82
All-time high date	2024-09-03
All-time low	BRL 225.30
All-time low date	2020-01-30
Average true range (ATR)	BRL 13.54
Average volume	45.4
Beta (5Y)	0.71
Change from 52-week high	-7.58%
Change from 52-week low	39.93%
Change from all-time high	-36.91%
Change from all-time low	78.87%
Change from open	0%
Day's gap	0%
High price	BRL 403.00
Low price	BRL 403.00
Monthly RSI	49.36
Open price	BRL 403.00
Previous close	BRL 403.00
Price vs 150-day SMA	-7.37%
Price vs 20-day SMA	4.54%
Price vs 200-day SMA	-13.14%
Price vs 50-day SMA	9.83%
Relative volume	0.04
RSI	55.7
Sharpe ratio	-0.12
Sortino ratio	-0.07
Volume	0
Weekly RSI	50.17
YTD price change	4.38%
YTD total return	5.42%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	215.6M
Shares change (QoQ)	-0.14%
Shares change (YoY)	-3.33%
Shares held by insiders	0.11%
Shares held by institutions	95.7%
Short ratio	4.4 days

Deeper analysis on BVMF/E1LV34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/E1LV34 report

Is a complete BVMF/E1LV34 research report available?

No complete published report is available for bvmf/E1LV34 (BVMF/E1LV34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/E1LV34 (BVMF/E1LV34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/E1LV34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/E1LV34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/E1LV34

Frequently asked questions